- Email: [email protected]
Corrigendum to “History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results” [J. Clin. Virol. 45 (1) (2009) S3–S12]
Journal of Clinical Virology 47 (2010) 299
Contents lists available at ScienceDirect
Journal of Clinical Virology journal homepage: www.elsevier.com/locate/jcv
Corrigendum
Corrigendum to “History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results” [J. Clin. Virol. 45 (1) (2009) S3–S12] J. Thomas Cox President, American Society for Colposcopy and Cervical Pathology (ASCCP), Director, Women’s Clinic, Student Health Services, University of California Santa Barbara, Santa Barbara, CA 93106, USA
In the article above I identified the 1989 article by Tidy et al.1 as the first study on the utility of HPV testing in a clinical setting. However, a December 1988 letter published in Lancet by Morris and colleagues2 described the evaluation of the first use of a new polymerase chain reaction (PCR) HPV test in 107 women attending a sexually transmitted disease clinic in Sydney. All women received cytology, colposcopy and cervicography in addition to the collection of exfoliated cells for HPV testing. The study, subsequently published as an original article in early 1989 in the J Clin Virol,3 compared PCR testing for HPVs 6, 11, 16, 18 and 33 with dot blot hybridization techniques to determine the suitability of the PCR test for implementation in routine clinical settings. The authors reported that, to their knowledge, this was the first report to describe the use of PCR for HPV detection in routine cervical specimens, and predicted that it was possible that such tests might gain widespread use in cervical cancer screening. The authors also pointed out in this 1989 paper that as early as 1984 a number of prior studies had looked at the use of filter hybridization techniques for detection of HPV DNA in cervical scrape specimens collected in parallel with samples for routine cytology.4–9 Hence, all of these investigators should receive due credit for pioneering the earliest studies on the clinical utility of HPV testing. References 1. Tidy JA, Mason WP, Farrell PJ. A new and sensitive method of screening for human papillomavirus infection. Obstet Gynecol 1989;74:410–4. 2. Morris BJ, Flanagan JL, McKinnon KJ. Nightengale BN Letter. Lancet 1988:1368. 3. Dallas PB, Flanagan JL, Nightingale, Morris BJ. Polymerase chain reaction for fast, nonradioactive detection of high- and low-risk papillomavirus types in routine cervical specimens and in biopsies. J Med Virol 1989;27:105–11. 4. Wagner D, Ikenberg H, Boehm N, Gissmann L. Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol 1984;64:767–72. 5. Wickenden C, Steele A, Malcolm ADB, Coleman DV. Screening for wart virus infection in normal and abnormal cervices by DNA hybridization of cervical scrapes. Lancet 1984;i:65–7. 6. Schneider A, Kraus H, Schumann R, Gissmann L. Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer 1985;35:448–1448. 7. Burk RD, Kadish AS, Calderin S, Romey SL. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization. Correlation with biopsy results in Papanicolaou smear. Am J Obstet Gyencol 1986;154:982–9. 8. Webb DH, Rogers RE, Fife KH. A one-step method for detecting and typing human papillomavirus DNA in cervical specimens from women with cervical dysplasia. J Infect Dis 1987;156:912–9. 9. Henderson BR, Thompson CH, Rose BR, Cossart YE, Morris BJ. Detection of specific types of human papillomavirus in cervical scrapes, anal scrapes, and anogenital biopsies by DNA hybridization. J Med Virol 1987;12:381–98.
PII of original article:S1386-6532(09)X0008-9 E-mail address: [email protected]. 1386-6532/$ – see front matter doi:10.1016/j.jcv.2009.12.009
Contents lists available at ScienceDirect
Journal of Clinical Virology journal homepage: www.elsevier.com/locate/jcv
Corrigendum
Corrigendum to “History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results” [J. Clin. Virol. 45 (1) (2009) S3–S12] J. Thomas Cox President, American Society for Colposcopy and Cervical Pathology (ASCCP), Director, Women’s Clinic, Student Health Services, University of California Santa Barbara, Santa Barbara, CA 93106, USA
In the article above I identified the 1989 article by Tidy et al.1 as the first study on the utility of HPV testing in a clinical setting. However, a December 1988 letter published in Lancet by Morris and colleagues2 described the evaluation of the first use of a new polymerase chain reaction (PCR) HPV test in 107 women attending a sexually transmitted disease clinic in Sydney. All women received cytology, colposcopy and cervicography in addition to the collection of exfoliated cells for HPV testing. The study, subsequently published as an original article in early 1989 in the J Clin Virol,3 compared PCR testing for HPVs 6, 11, 16, 18 and 33 with dot blot hybridization techniques to determine the suitability of the PCR test for implementation in routine clinical settings. The authors reported that, to their knowledge, this was the first report to describe the use of PCR for HPV detection in routine cervical specimens, and predicted that it was possible that such tests might gain widespread use in cervical cancer screening. The authors also pointed out in this 1989 paper that as early as 1984 a number of prior studies had looked at the use of filter hybridization techniques for detection of HPV DNA in cervical scrape specimens collected in parallel with samples for routine cytology.4–9 Hence, all of these investigators should receive due credit for pioneering the earliest studies on the clinical utility of HPV testing. References 1. Tidy JA, Mason WP, Farrell PJ. A new and sensitive method of screening for human papillomavirus infection. Obstet Gynecol 1989;74:410–4. 2. Morris BJ, Flanagan JL, McKinnon KJ. Nightengale BN Letter. Lancet 1988:1368. 3. Dallas PB, Flanagan JL, Nightingale, Morris BJ. Polymerase chain reaction for fast, nonradioactive detection of high- and low-risk papillomavirus types in routine cervical specimens and in biopsies. J Med Virol 1989;27:105–11. 4. Wagner D, Ikenberg H, Boehm N, Gissmann L. Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol 1984;64:767–72. 5. Wickenden C, Steele A, Malcolm ADB, Coleman DV. Screening for wart virus infection in normal and abnormal cervices by DNA hybridization of cervical scrapes. Lancet 1984;i:65–7. 6. Schneider A, Kraus H, Schumann R, Gissmann L. Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer 1985;35:448–1448. 7. Burk RD, Kadish AS, Calderin S, Romey SL. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization. Correlation with biopsy results in Papanicolaou smear. Am J Obstet Gyencol 1986;154:982–9. 8. Webb DH, Rogers RE, Fife KH. A one-step method for detecting and typing human papillomavirus DNA in cervical specimens from women with cervical dysplasia. J Infect Dis 1987;156:912–9. 9. Henderson BR, Thompson CH, Rose BR, Cossart YE, Morris BJ. Detection of specific types of human papillomavirus in cervical scrapes, anal scrapes, and anogenital biopsies by DNA hybridization. J Med Virol 1987;12:381–98.
PII of original article:S1386-6532(09)X0008-9 E-mail address: [email protected]. 1386-6532/$ – see front matter doi:10.1016/j.jcv.2009.12.009